Skip to content
healthcare.dev
Get a free key

Abacavir and Lamivudine

NDC 69097-362, Abacavir and lamivudine, tablet, film coated, from Cipla USA Inc..

Product NDC
69097-362
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091144
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-362 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABACAVIR SULFATE600 mg/1
  • LAMIVUDINE300 mg/1

Pharmacologic classes

Cytochrome P450 1A1 Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
69097-362-026909703620230 TABLET, FILM COATED in 1 BOTTLE (69097-362-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c0488bee-2f18-4e2e-8e11-68543c023dec

  • NADAC price for package 69097036202

    GET /v1/drugs/nadac/69097036202

Use it

Look up 69097-362 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-362 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-362. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.